https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520-%2520RW%2520Baird%2520Conference%2520w%2520non-GAAP.pdf
PolyOne Corporation Page 4
PolyOne Commodity to Specialty
Transformation
• Volume driven,
commodity
producer
• Heavily tied to
cyclical end
markets
• Performance largely
dependent on non-
controlling joint
ventures
2000-2005 2006 - 2009 2010 – 2014
2015 and
beyond
• Steve Newlin
appointed,
Chairman,
President and CEO
• New leadership
team appointed
• Implementation of
four pillar strategy
• Focus on value
based selling,
investment in
commercial
resources and
innovation to drive
transformation
• 20 consecutive
quarters of double-
digit adjusted EPS
growth
• Shift to faster
growing, high
margin, less cyclical
end markets
• Key acquisitions
propel current and
future growth, as
well as margin
expansion
• Established
aggressive 2015
targets
• Continue specialty
transformation
• Goal of $2.50
adjusted EPS by
2015, three times
the EPS generated
in 2011 of $0.82
• Drive double digit
operating income
and adjusted EPS
growth
PolyOne Corporation Page 5
Building &
Construction
13%
Industrial
12%
Transportation
18%
Wire & Cable
9%
Packaging
16%
Consumer
10%
HealthCare
11% Appliance
Electronics &
Electrical
5%
2013 Revenues: $3.8 Billion
End Markets
2013 Revenues: $3.8 Billion
PolyOne
At A Glance
United
States
67%
Europe
14%
Canada
7%
Asia
Latin
America
Specialty
54%
PP&S
18%
Distribution
28%
$13
$31
$46 $46
$92 $96
$122
$195
$0
$50
$100
$150
$200
2006 2007 2008 2009 2010 2011 2012 2013
Specialty Operating Income
PolyOne Corporation Page 6
Old
PolyOne
*Operating Income excludes corporate charges and special items
2%
34%
43%
62%
65%
0%
20%
40%
60%
80%
100%
2005 2008 2010 2013 2014 YTD 2015
%
o
f
O
p
e
ra
ti
n
g
I
n
c
o
m
e
*
JV's Performance Products & Solutions Distribution Specialty
65-75%
Specialty OI $5M $46M $87M $195M $191M Target
Mix Shift Highlights Specialty Transformation
Transformation
2015
Target
PolyOne Corporation Page 7
Confirmation of Our Strategy
The World’s Premier Provider of Specialized
Polymer Materials, Services and Solutions
Specialization Globalization
Operational
Excellence
Commercial
Excellence
PolyOne Corporation Page 8
Strategy and Execution Drive Results
$0.12
$0.27
$0.21
$0.13
$0.68
$0.82
$1.00
$1.31
'06 '07 '08 '09 '10 '11 '12 '13
‘06-‘13 EPS CAGR = 41%
EPS Share Price vs.
S&P 500
-150%
-50%
50%
150%
250%
350%
450%
550%
POL S&P 500
All time high of
$43.34
July 1st, 2014
PolyOne Corporation Page 9
2006 2014 YTD 2015
“Where we were” “Where we are” Target
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 14.9% 12 – 16%
Global Specialty Engineered
Materials
1.1% 12.1% 12 – 16%
Designed Structures & Solutions -- 7.6% 8 – 10%
Performance Products &
Solutions
5.5% 8.1% 9 – 12%
Distribution 2.6% 6.2% 6 – 7.5%
2) Specialty Platform % of
Operating Income
6.0% 65% 65 – 75%
3) ROIC* 5.0% 10.6% 15%
4) Adjusted EPS Growth N/A 37%
Double Digit
Expansion
Proof of Performance & 2015 Goals
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period
PolyOne Corporation Page 10
32% Adjusted EPS CAGR from 2011
2015 EPS: $2.50
2011 EPS: $0.82
Continued Gross Margin
Expansion
Mergers & Acquisitions
Spartech Accretion
Incremental Share Buybacks
Ongoing LSS Programs
(50-100 bps/yr)
Accelerated Innovation
& Mix Improvement
Several Levers to
Drive Growth
Mid Single Digit Revenue Growth
PolyOne Corporation Page 11
Innovation Drives Earnings Growth
*Percentage of Specialty Platform revenue from products introduced in last five years
$20
$53
2006 2013
Research & Development
Spending
($ millions)
Specialty Platform
Vitality Index Progression*
14%
31%
2006 2013
Specialty Platform
Gross Margin %
20%
43%
2006 2013
Specialty Vitality Index Target ≥ 35%
Vitality Products
+ 700 to 1000 bps
PolyOne Corporation Page 12
Prototype Frame
Opportunity
Scale-up &
Test Market
Build
Business Case
Commercial
Launch
Phase
1
Phase
2
Phase
3
Phase
4
Phase
5
4
11
5
10
6
9
3 4 2
15
9
1
10
4
Breakthrough
Platform
Derivative
A Rich Pipeline of Opportunity
Number of Projects 25 14 19 17 18 93
Addressable Market
($ millions)
TBD TBD $800 $450 $450 $1,700
PolyOne Corporation Page 13
Megatrends Aligned with Key End Markets
Decreasing
Dependence
on Fossil
Fuels
Protecting
the
Environment
Improving
Health and
Wellness
Megatrend End Markets
Globalizing
and
Localizing
Health &
Wellness
Transportation
Packaging
Consumer
PolyOne Corporation Page 14
60%
100%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2008 2014
Pension Funding**
As of September 30, 2014
Debt Maturities & Pension Funding – 9/30/14
Net Debt / EBITDA* = 1.7x
$48
$317
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Debt Maturities
As of September 30, 2014
($ millions)
Coupon Rates: 7.500% 7.375% 5.250%
** includes US-qualified pension plans only *TTM 9/30/2014
PolyOne Corporation Page 15
Free Cash Flow and Strong Balance Sheet
Fund Investment / Shareholder Return
Expanding our sales, marketing,
and technical capabilities
Targets that expand our:
• Specialty offerings
• End market presence
• Geographic footprint
• Operating Margin
Synergy opportunities
Adjacent material solutions
Repurchased 1.5 million shares in
Q3 2014
Repurchased 9.7 million
shares since early 2013
10.3 million shares are
available for
repurchase under the
current authorization
Organic
Growth
Acquisitions
Share
Repurchases
Dividends
Investing in operational and
LSS initiatives (including
synergy capture)
Manufacturing alignment
$0.16
$0.20
$0.24
$0.32
$0.40
$0.10
$0.20
$0.30
$0.40
$0.50
2011 2012 2013 2014 2015
Annual Dividend
PolyOne Corporation Page 16
PolyOne Core Values
Innovation
Collaboration
Excellence
PolyOne Corporation Page 17
The New PolyOne: A Specialty Growth Company
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/2025-03/380605_AVIENT_2024AR_full_250325.pdf
Avient Stock Performance
The following is a graph that compares the cumulative total shareholder returns for Avient’s common shares, the S&P 500 index and the
S&P Mid Cap Chemicals index, with dividends assumed to be reinvested when received.
The S&P Mid Cap Chemicals index includes a broad range of chemical manufacturers.
https://www.avient.com/sites/default/files/2025-04/CCG PVDF Monofilament Case Study Snapshot.pdf
MONOFILAMENT
MANUFACTURER
P V D F F I L A M E N T E X T R U S I O N
• Reduce or eradicate die build-up
• Improve predictive and final part quality
• Optimize PVDF extrusion for the desired coefficient of
friction (CoF)
• Reduce energy consumption
• Boosted overall production efficiency by
minimizing die build-up through use of a
PVDF-specific processing aid
• Achieved a flawless surface by reducing
friction and improving flow for enhanced
final part quality
• Controlled extrusion pressure to reduce
energy required in processing
Colorant Chromatics PVDF Processing Aid
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2023-05/OnColor Combination MIC Color - Center Console - Application Snapshot.pdf
AUTOMOTIVE OEM
C E N T R A L C O N S O L E P A R T
• Metallic aspect
• Good surface appearance
• UV resistance
• Cost effective alternative to paint
• Offered a paint replacement solution with a
molded-in-color metallic effect
• Provided color matching expertise
• Utilized simulation tools to predict part
aspect and suggest the best injection point
for process and mold optimization
• Optimized formulation for metallic effects
Smartbatch™ Combination Colorants &
Additives
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2022-10/Potable Water Tanks Mini Case Study.pdf
WATER STORAGE
MANUFACTURER
P O T A B L E W A T E R T A N K S
• Diminish growth of microbials in water tanks to provide
differentiating feature for landmark product launch
• Prevent undesirable odor associated with bacteria and
fungal growth on the product’s polymer surface
• Meet FDA, NSF, and UL regulatory requirements
• Formulated a multi-polymer solution that
ensured microbial and fungal growth were
diminished while preserving polymer
performance
• Utilized antimicrobials to mitigate the causal
effect of undesirable tastes and odors
• Enabled customer to meet requirements
through Avient’s knowledge and expertise of
regulatory protocols
Cesa™ WithStand™ Antimicrobial Additives
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2024-05/Mevopur-Surgical Gown-Case study snapshot_0520.pdf
Medical textile manufacturer
LEARN MORE
MEDICAL TEXTILE
MANUFACTURER
S U R G I C A L D R A P E S & G O W N S
• Pre-tested for ISO 10993 biocompatibility standard
• Available in standard blue or other customized colors
• Compatible with ETO sterilization
• Suitable for use in non-woven SMS spunbond layer
• Offered standard blue and custom colors
such as green
• Pre-tested raw materials for biocompatibility
ISO10993 standard
• Manufactured under ISO 13485 certified
medical sites with change control in place
MevopurTM Healthcare Colorants and
Formulations
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2020-12/stat-tech-fire-alarm-case-study-brief.pdf
DONGGUAN
FYRNETICS
F I R E A L A R M C O M P O N E N T S
• Excellent conductive performance, EMI shielding
• Excellent IR absorption
• Quality stability
• Formulated material to meet all customer’s
CTQs and support sensor’s certification for
sensitivity and accuracy
• Provided shorter lead time than previous
material supplier, plus excellent service to
support material change
• Tested surface resistivity using ASTM D257
method, achieving result of E3-E4
Stat-Tech™ ST7400-8010 ESD Formulations
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2021-06/maxxam-fr-battery-pack-case-study-one-pager.pdf
POWER TOOL
COMPANY
B A T T E R Y P A C K
• HDPE based solution
• Meet flammability performance requirement for UL94 V-0
• Consistent color and global availability
• Provided global technical services to
enable consistent material quality in
Europe and Asia
• Tested and verified flame retardant
performance conforming to UL94 V-0 @
1.5 and 3.0 mm, GWFI 960°C
• Delivered a pre-colored, HDPE-based
solution for color uniformity globally
Maxxam ™ FR Formulation
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2021-07/eccoh-optical-cable-sheath-case-study-one-pager.pdf
WIRE &CABLE
COMPANY
O P T I C A L C A B L E S H E A T H
• Excellent resistance to fungi and mildew
• Good UV resistance
• Meet flame retardant standard IEC 60332-3C
• Provided an anti-fungi solution with an ISO
846 rating of 0, showing no growth under
microscope
• Formulated solution to meet flammability
performance demands for IEC60332-2 or
GBT 18380.22-2008 compliance
• Complied with Biocidal Product Regulation
(EU) No528/2012 (BPR)
ECCOH™ Thermoplastic Formulation
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2020-08/case-study-one-pager-gravi-tech-kitchen-knife-handle.pdf
CUTLERY MAKER
P R E M I U M K I T C H E N K N I V E S
• Replaced aluminum while providing the same premium
weight and feel of a metal
• Withstand dishwashing without the discoloration issues of
aluminum handles
• Streamlined the design and molding
phase, working directly with the
manufacturer
• Enabled the customer to expand their
product line, providing a dishwasher safe
kitchen knife into the market
Gravi-Tech™ Density Modified Material
KEY REQUIREMENTS
WHY AVIENT?